|
- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30441
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
本帖最后由 StephenW 于 2012-3-9 08:57 编辑
| Cuba to Exhibit Progress in Therapeutic Vaccine against Hepatitis B |
|
|
|
|
|  Havana, Mar 8 (Prensa Latina) Cuban experts are working on a vaccine candidate against hepatitis B, which encouraging results in clinical trials will be presented on Thursday at the Congress Biotecnologia 2012.
During the clinical trials carried out in Cuba and Bangladesh, Nasvac reported a better response than any other compound to treat that illness, Doctor Gerardo Guillén, vice president of the Organizing Committee of the event told reporters.
Nasvac allows leading the patients' immune response to the virus and preventing the disease from worsening, the expert said.
Effectiveness and benefits are already palpable, he said.
Participants in the congress also learned about the results of clinical trials of anothr therapeutic vaccine against hepatitis C, as well as a drug against womb cancer.
Regarding the vaccine against womb cancer, the head of the Research Project and Product Development at the Havana-based Genetic Engineering and Biotechnology Center (CIGB), Silvio Perea, told Prensa Latina that it is a synthetic peptide capable of blocking the enzyme casein kinase two (CK2), causing the programmed death of tumor cells.
古巴参展对乙型肝炎PDF Imprimir电子邮件的治疗性疫苗的研究进展
IMAGEN activaHavana，3月8日（拉丁新闻社）古巴专家正在对候选疫苗对B型肝炎，在临床试验的结果令人鼓舞，将于周四在国会Biotecnologia2012。
在古巴和孟加拉国进行的临床试验期间，Nasvac报道事件组委会副总裁赫拉尔多·纪廉，更好的反应比任何其他化合物治疗疾病，医生告诉记者。
专家说，nasvac可以导致病人的免疫反应的病毒，防止疾病恶化。
有效性和好处已经显而易见的，“他说。
在大会的与会者还了解anothr抗丙型肝炎治疗性疫苗，以及对子宫癌的药物临床试验的结果。
关于对子宫癌的疫苗，在哈瓦那遗传工程和生物技术中心（CIGB），西尔维奥·佩雷亚，该研究项目和产品开发的负责人告诉新闻报拉丁，它是一种人工合成的肽能够阻断酶酪蛋白激酶两种（CK2的），导致肿瘤细胞程序化死亡。
|
|
-
总评分: 现金 + 2
查看全部评分
|
楼主: StephenW
发表于 2012-3-8 20:45
